The antigen kit generally refers to novel coronavirus antigen kit. Generally, some pharmacies in novel coronavirus can swipe their medical insurance cards, because some areas have included novel coronavirus antigen detection reagents in the payment scope of employees' medical insurance personal accounts.
Novel coronavirus antigen kit is a commonly used method to detect whether there is novel coronavirus infection in the body, mainly through the binding reaction between antigen and antibody on the reagent strip. With the development of novel coronavirus, in order to strengthen medical insurance for epidemic prevention and control, some areas have optimized epidemic prevention and control measures, allowing employees' personal medical insurance accounts to pay for novel coronavirus antigen kits, so some areas can purchase medical insurance.
Medical insurance coverage:
1, drug reimbursement for basic medical insurance
Our country now divides drugs into three categories: A, B and C, among which A drugs are within the scope of medical insurance, so medical insurance can only reimburse A drugs, and B and C drugs cannot be reimbursed;
2. Reimbursement of basic medical service facilities
This reimbursement scope mainly refers to bed fees, first-aid bed fees, consulting fees, etc. Expenses incurred by the insured in the process of diagnosis, treatment and nursing in designated medical insurance institutions;
3, the basic medical insurance treatment project reimbursement
It must be a safe and effective diagnosis and treatment, and the charging standard shall be determined by the price department. Need to be treated in a designated medical institution.
To sum up, the antigen detection reagents and corresponding detection items in COVID-19 are temporarily included in the basic medical insurance medical service project catalogue, and the related expenses incurred by the insured in the designated primary medical institutions are paid according to the current regulations in the overall planning area.
Legal basis:
Article 28 of People's Republic of China (PRC) Social Insurance Law
Medical expenses that meet the basic medical insurance drug list, diagnosis and treatment items, medical service facilities standards and emergency rescue shall be paid by the basic medical insurance fund in accordance with state regulations.
Article 29
The medical expenses of the insured shall be paid by the basic medical insurance fund, and shall be directly settled by social insurance agencies, medical institutions and pharmaceutical business units.
The administrative department of social insurance and the administrative department of health shall establish a settlement system for medical expenses in different places to facilitate the insured to enjoy the basic medical insurance benefits.